Newsroom

Press Releases

Announcements, partnerships and financial updates from OneMedNet Corporation.

October 19, 2026

OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market

Agreement with a leading global provider of pharmaceutical intelligence and data solutions expands distribution of OneMedNet’s first-party, direct-from-source multimodal Real-World Data; Strengthening its presence in a…

October 15, 2026

OneMedNet Adds Leading Hospital System to Provider Network, Expanding By Up to 12 Hospitals

Direct-from-Source Access Deepens Longitudinal Clinical Records, Strengthening OneMedNet’s Position as a Preferred Source of Regulatory-Grade, AI-Ready Real-World Data. OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,”…

October 7, 2026

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

Agreement with Mediplexus, a subsidiary of Korean CRO C&R Research, establishes a new Asia Pacific distribution channel for OneMedNet’s first-party, direct-from-source multimodal Real-World Data OneMedNet Corporation…

September 30, 2026

OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution

First party, direct-from-source Real World Data will feed the Company’s tenth channel partner’s AI models and a licensable derivative dataset that partner will sell . OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet,"…

September 25, 2026

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it will…

September 22, 2026

OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health

OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us,” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced a strategic partnership with…

September 18, 2026

OneMedNet Reports Record Bookings as Faster Fulfillment Begins

Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, , datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these…

August 31, 2026

OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

Customer selects OneMedNet for the full-fidelity studies and regulatory decision-grade quality required to develop AI models that accelerate drug development OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the…

July 28, 2026

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

Validates OneMedNet ’ s Position as Premier Supplier of High-Quality Healthcare Data for Advanced AI Training. OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider…

June 10, 2026

OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025

Strong Commercial Momentum Fueled by Demand for Regulatory-Grade Multi-Modal Real-World Data OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory…

June 3, 2026

OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network

~Network Expands to More Than 2,300 Healthcare Partner Sites, Advancing the Company’s Strategic Network-Growth~ OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading…

April 22, 2026

OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records

~ Searchable in Seconds Powered by Palantir Foundry ~ OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Real-World…

April 6, 2026

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), highlights its 2025 results, with robust…

April 1, 2026

OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), is pleased to announce that Inka Health, a…

March 18, 2026

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights

February 27, 2026

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry.

OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced the next phase of commercial launch…

February 26, 2026

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers

OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic partnership with ViuHealth, a digital health company specializing in autoimmune…

February 24, 2026

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company…